Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD study of degarelix in benign prostatic hyperplasia
2007-003578-24Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of degarelix in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Pharmacodynamic endpoints, Pharmacokinetic endpoints and 1 more. Started Sep 2007; status: completed.
02
Drugs
degarelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2007-003578-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003578-24.